MUMBAI, India, July 13 -- Intellectual Property India has published a patent application (202617071280 A) filed by Cytiva Bioprocess R&d Ab on June 08, 2026, for Antibody Separation With A Vh3 Binding Separation Matrix.
Inventors include Bjrkman, Tomas; Knutsson, Ulrika; and Rodrigo, Gustav.
The application for the patent was published on July 10, 2026, under issue no. 28/2026.
Abstract: The present invention relates to processes of isolation of VH3 comprising antibodies or antibody fragments using a Protein A affinity separation matrix capable of binding VH3, wherein the elution buffer is a mono-, di- or tricarboxylic acid at a concentration of 50 mM or less. It further relates to a process for separation of bispecific antibodies or antibody fragments comprising one VH3 chain from antibodies or antibody fragments comprising two or more VH3 chain fragments.
Disclaimer: Curated by HT Syndication.
